Cargando…

Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis

Anticholinergics (ACs) are among the most prescribed drugs. Investigating the impaired cognitive domains due to individual ACs usage is associated with controversial findings. OBJECTIVE: The objective of this study was to investigate the effects of individual ACs on different aspects of cognitive fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Naseri, Amirreza, Sadigh-Eteghad, Saeed, Seyedi-Sahebari, Sepideh, Hosseini, Mohammad-Salar, Hajebrahimi, Sakineh, Salehi-Pourmehr, Hanieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229087/
https://www.ncbi.nlm.nih.gov/pubmed/37261256
http://dx.doi.org/10.1590/1980-5764-DN-2022-0053
_version_ 1785051163928821760
author Naseri, Amirreza
Sadigh-Eteghad, Saeed
Seyedi-Sahebari, Sepideh
Hosseini, Mohammad-Salar
Hajebrahimi, Sakineh
Salehi-Pourmehr, Hanieh
author_facet Naseri, Amirreza
Sadigh-Eteghad, Saeed
Seyedi-Sahebari, Sepideh
Hosseini, Mohammad-Salar
Hajebrahimi, Sakineh
Salehi-Pourmehr, Hanieh
author_sort Naseri, Amirreza
collection PubMed
description Anticholinergics (ACs) are among the most prescribed drugs. Investigating the impaired cognitive domains due to individual ACs usage is associated with controversial findings. OBJECTIVE: The objective of this study was to investigate the effects of individual ACs on different aspects of cognitive function based on clinical trial studies. METHODS: This systematic review was conducted following the PRISMA statement. A systematic search was performed in Embase, PubMed, Cochrane Library, Scopus, and Web of Science databases. Risk of bias (RoB) was assessed by the Joanna Briggs Institute checklists and the meta-analysis was performed using the CMA software. RESULTS: Out of 3,026 results of searching, 138 studies were included. A total of 38 studies that assess the cognitive impacts of scopolamine were included in the meta-analysis. Included studies reported cognitive effects of scopolamine, mecamylamine, atropine, biperiden, oxybutynin, trihexyphenidyl, benzhexol, and dicyclomine; however, glycopyrrolate, trospium, tolterodine, darifenacin, fesoterodine, tiotropium, and ipratropium were not associated with cognitive decline. Based on the meta-analyses, scopolamine was associated with reduced recognition (SDM -1.84; 95%CI -2.48 to -1.21; p<0.01), immediate recall (SDM -1.82; 95%CI -2.35 to -1.30; p<0.01), matching to sample (SDM -1.76; 95%CI -2.57 to -0.96; p<0.01), delayed recall (SDM -1.54; 95%CI -1.97 to -1.10; p<0.01), complex memory tasks (SDM -1.31; 95%CI -1.78 to -0.84; p<0.01), free recall (SDM -1.18; 95%CI -1.63 to -0.73; p<0.01), cognitive function (SDM -0.95; 95%CI -1.46 to -0.44; p<0.01), attention (SDM -0.85; 95%CI -1.38 to -0.33; p<0.01), and digit span (SDM -0.65; 95%CI -1.21 to -0.10; p=0.02). There was a high RoB in our included study, especially in terms of dealing with possible cofounders. CONCLUSION: The limitations of this study suggest a need for more well-designed studies with a longer duration of follow-up on this topic to reach more reliable evidence.
format Online
Article
Text
id pubmed-10229087
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento
record_format MEDLINE/PubMed
spelling pubmed-102290872023-05-31 Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis Naseri, Amirreza Sadigh-Eteghad, Saeed Seyedi-Sahebari, Sepideh Hosseini, Mohammad-Salar Hajebrahimi, Sakineh Salehi-Pourmehr, Hanieh Dement Neuropsychol View & Review Anticholinergics (ACs) are among the most prescribed drugs. Investigating the impaired cognitive domains due to individual ACs usage is associated with controversial findings. OBJECTIVE: The objective of this study was to investigate the effects of individual ACs on different aspects of cognitive function based on clinical trial studies. METHODS: This systematic review was conducted following the PRISMA statement. A systematic search was performed in Embase, PubMed, Cochrane Library, Scopus, and Web of Science databases. Risk of bias (RoB) was assessed by the Joanna Briggs Institute checklists and the meta-analysis was performed using the CMA software. RESULTS: Out of 3,026 results of searching, 138 studies were included. A total of 38 studies that assess the cognitive impacts of scopolamine were included in the meta-analysis. Included studies reported cognitive effects of scopolamine, mecamylamine, atropine, biperiden, oxybutynin, trihexyphenidyl, benzhexol, and dicyclomine; however, glycopyrrolate, trospium, tolterodine, darifenacin, fesoterodine, tiotropium, and ipratropium were not associated with cognitive decline. Based on the meta-analyses, scopolamine was associated with reduced recognition (SDM -1.84; 95%CI -2.48 to -1.21; p<0.01), immediate recall (SDM -1.82; 95%CI -2.35 to -1.30; p<0.01), matching to sample (SDM -1.76; 95%CI -2.57 to -0.96; p<0.01), delayed recall (SDM -1.54; 95%CI -1.97 to -1.10; p<0.01), complex memory tasks (SDM -1.31; 95%CI -1.78 to -0.84; p<0.01), free recall (SDM -1.18; 95%CI -1.63 to -0.73; p<0.01), cognitive function (SDM -0.95; 95%CI -1.46 to -0.44; p<0.01), attention (SDM -0.85; 95%CI -1.38 to -0.33; p<0.01), and digit span (SDM -0.65; 95%CI -1.21 to -0.10; p=0.02). There was a high RoB in our included study, especially in terms of dealing with possible cofounders. CONCLUSION: The limitations of this study suggest a need for more well-designed studies with a longer duration of follow-up on this topic to reach more reliable evidence. Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento 2023-05-29 /pmc/articles/PMC10229087/ /pubmed/37261256 http://dx.doi.org/10.1590/1980-5764-DN-2022-0053 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle View & Review
Naseri, Amirreza
Sadigh-Eteghad, Saeed
Seyedi-Sahebari, Sepideh
Hosseini, Mohammad-Salar
Hajebrahimi, Sakineh
Salehi-Pourmehr, Hanieh
Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis
title Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis
title_full Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis
title_fullStr Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis
title_full_unstemmed Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis
title_short Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis
title_sort cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis
topic View & Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229087/
https://www.ncbi.nlm.nih.gov/pubmed/37261256
http://dx.doi.org/10.1590/1980-5764-DN-2022-0053
work_keys_str_mv AT naseriamirreza cognitiveeffectsofindividualanticholinergicdrugsasystematicreviewandmetaanalysis
AT sadigheteghadsaeed cognitiveeffectsofindividualanticholinergicdrugsasystematicreviewandmetaanalysis
AT seyedisahebarisepideh cognitiveeffectsofindividualanticholinergicdrugsasystematicreviewandmetaanalysis
AT hosseinimohammadsalar cognitiveeffectsofindividualanticholinergicdrugsasystematicreviewandmetaanalysis
AT hajebrahimisakineh cognitiveeffectsofindividualanticholinergicdrugsasystematicreviewandmetaanalysis
AT salehipourmehrhanieh cognitiveeffectsofindividualanticholinergicdrugsasystematicreviewandmetaanalysis